Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (68 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 08 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Bank of India ELSS Tax Saver |
|---|---|
| 08 Jan 2013 | ₹100.00 |
| 26 Feb 2014 | ₹110.50 |
| 17 Apr 2015 | ₹163.17 |
| 04 Jun 2016 | ₹157.13 |
| 23 Jul 2017 | ₹206.43 |
| 11 Sep 2018 | ₹208.31 |
| 30 Oct 2019 | ₹212.62 |
| 17 Dec 2020 | ₹275.78 |
| 05 Feb 2022 | ₹348.51 |
| 26 Mar 2023 | ₹337.15 |
| 13 May 2024 | ₹554.55 |
| 02 Jul 2025 | ₹591.07 |
| 20 Aug 2026 | ₹619.83 |
| Metric | Bank of India · Direct · IDCW NAV ₹79.09 Very High risk ★★★☆☆ | Category median ELSS · 68 funds |
|---|---|---|
| +7.33% | +2.22% | |
| +15.38% | +9.76% | |
| +13.20% | +8.88% | |
| +13.69% | +10.68% | |
| +14.34% | +10.64% | |
| +13.02% | — | |
| +15.01% | +11.55% | |
| +14.42% | +12.14% | |
| +14.65% | +10.94% | |
| Risk | ||
| 17.41% | 14.08% | |
| 0.51 | 0.32 | |
| 0.67 | 0.44 | |
| -34.89% | -35.52% | |
| Nifty 500 | — | |
| +2.92% | -1.42% | |
| 1.07 | 0.96 | |
| 116.3% | 91.4% | |
| 107.9% | 94.7% | |
| 1.06% | 1.17% | |
| ₹1,383Cr | ₹694.87Cr | |
| None | — | |
| 3 years | — | |
| ₹500 | — | |
| ₹500 | — | |
| 31% | 33% | |
| Alok Singh · 4.3y | — | |
| 08 Jan 2013 | — | |
| 56 | — | |
| 33.1% | — | |
| 7.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.